Essix Biosciences Limited has submitted a disclosure under Regulation 10(5) of SEBI (SAST) Regulations, 2011 regarding the acquisition of 16.08% equity shares held by Ind-Swift Limited in Ind-Swift Laboratories Limited.
AI Assistant
Ind-Swift Laboratories Ltd
2024
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.